Clinical data | |
---|---|
Pronunciation | /ˌnælˈtrɛksoʊn/ |
Trade names | Revia, Vivitrol, Depade, others |
Other names | EN-1639A; UM-792; ALKS-6428; N-cyclopropylmethylnoroxymorphone; N-cyclopropylmethyl-14-hydroxydihydromorphinone; 17-(cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxymorphinan-6-one |
AHFS/Drugs.com | Monograph |
MedlinePlus | a685041 |
License data |
|
Pregnancy category |
|
Routes of administration | By mouth, intramuscular injection, subcutaneous implant |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 5–60%[6][7] |
Protein binding | 20%[6][3] |
Metabolism | Liver (non-CYP450)[11] |
Metabolites | 6β-Naltrexol, others[6] |
Onset of action | 30 minutes[8] |
Elimination half-life | Oral (Revia):[3] • Naltrexone: 4 hours • 6β-Naltrexol: 13 hours Oral (Contrave):[4] • Naltrexone: 5 hours IM (Vivitrol):[5] • Naltrexone: 5–10 days • 6β-Naltrexol: 5–10 days |
Duration of action | >72 hours[6][9][10] |
Excretion | Urine[3] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.036.939 |
Chemical and physical data | |
Formula | C20H23NO4 |
Molar mass | 341.407 g·mol−1 |
3D model (JSmol) | |
Melting point | 169 °C (336 °F) |
| |
| |
(verify) |
Naltrexone, sold under the brand name Revia among others, is a medication primarily used to manage alcohol use or opioid use disorder by reducing cravings and feelings of euphoria associated with substance use disorder.[8] It has also been found effective in the treatment of other addictions and may be used for them off-label.[12] An opioid-dependent person should not receive naltrexone before detoxification.[8] It is taken by mouth or by injection into a muscle.[8] Effects begin within 30 minutes,[8] though a decreased desire for opioids may take a few weeks to occur.[8] Side effects may include trouble sleeping, anxiety, nausea, and headaches.[8] In those still on opioids, opioid withdrawal may occur.[8] Use is not recommended in people with liver failure.[8] It is unclear if use is safe during pregnancy.[8][13] Naltrexone is an opioid antagonist and works by blocking the effects of opioids, including both opioid drugs as well as opioids naturally produced in the brain.[8]
Naltrexone was first made in 1965 and was approved for medical use in the United States in 1984.[8][14] Naltrexone, as naltrexone/bupropion (brand name Contrave), is also used to treat obesity.[15] It is on the World Health Organization's List of Essential Medicines.[16] In 2021, it was the 254th most commonly prescribed medication in the United States, with more than 1 million prescriptions.[17][18]
pmid2836152
was invoked but never defined (see the help page).pmid19537999
was invoked but never defined (see the help page).ColasantiLingford-HughesNutt2013
was invoked but never defined (see the help page).pmid2839637
was invoked but never defined (see the help page).pmid27401883
was invoked but never defined (see the help page).© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search